Achromia of skin
|
phenotype |
Skin and Connective Tissue Diseases
|
Sign or Symptom
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Unspecified visual loss
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases
|
Sign or Symptom
|
235
|
11
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Photophobia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Sign or Symptom
|
227
|
7
|
0.100 |
None |
|
0 |
|
|
|
Choroidal Neovascularization
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases
|
Pathologic Function
|
31
|
3
|
0.100 |
None |
|
0 |
3
|
|
|
Eye Color
|
phenotype |
|
Organism Attribute
|
13
|
31
|
0.100 |
None |
1.000 |
2 |
2
|
2007 |
2010 |
Hair Color
|
phenotype |
|
Organism Attribute
|
130
|
312
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Suntan
|
phenotype |
|
Organ or Tissue Function
|
53
|
94
|
0.100 |
None |
1.000 |
3 |
2
|
2009 |
2018 |
Skin Pigmentation
|
phenotype |
|
Organ or Tissue Function
|
24
|
72
|
0.100 |
None |
1.000 |
2 |
3
|
2007 |
2018 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.050 |
None |
1.000 |
5 |
|
1988 |
2018 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.500 |
None |
0.984 |
191 |
4
|
1988 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.961 |
51 |
|
1994 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
25 |
|
1993 |
2019 |
Metastatic melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
504
|
42
|
0.100 |
None |
1.000 |
19 |
|
1994 |
2018 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.100 |
None |
1.000 |
15 |
|
1993 |
2018 |
Cutaneous Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
507
|
248
|
0.200 |
None |
1.000 |
14 |
2
|
1995 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.080 |
None |
1.000 |
8 |
|
1987 |
2019 |
Melanoma, Amelanotic
|
disease |
Neoplasms
|
Neoplastic Process
|
19
|
2
|
0.070 |
None |
1.000 |
7 |
|
1993 |
2012 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.070 |
None |
1.000 |
7 |
|
1987 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.050 |
None |
1.000 |
5 |
|
1996 |
2014 |
Uveal melanoma
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
376
|
22
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2010 |
Amelanotic Skin Melanoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
13
|
|
0.050 |
None |
1.000 |
5 |
|
1993 |
2012 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.040 |
None |
1.000 |
4 |
|
1995 |
2019 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.320 |
None |
1.000 |
3 |
1
|
2008 |
2011 |
Basal cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
108
|
109
|
0.110 |
None |
1.000 |
3 |
1
|
2008 |
2019 |
Squamous cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2507
|
257
|
0.110 |
None |
1.000 |
3 |
2
|
2009 |
2019 |